Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2024 | 06-2023 | 12-2022 | 12-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,165 | 2,479 | 41 | 479 | N/A |
| Other current assets | 0 | 273 | 0 | 0 | 0 |
| TOTAL | $4,454 | $2,752 | $52 | $616 | $N/A |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 9,671 | 45,187 | 0 |
| Other Non-Current Assets | 0 | 276 | 0 | 0 | 0 |
| TOTAL | $N/A | $276 | $9,671 | $45,187 | $N/A |
| Total Assets | $4,454 | $3,028 | $9,724 | $45,804 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 499 | N/A | 0 |
| Accounts payable and accrued liabilities | 132 | 9,732 | 379 | 3 | 0 |
| Accrued Expenses | 4 | 22 | N/A | N/A | 0 |
| TOTAL | $181 | $9,758 | $1,073 | $73 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 13 | 10,877 | 46,737 | 0 |
| TOTAL | $N/A | $13 | $10,906 | $46,737 | $N/A |
| Total Liabilities | $181 | $9,771 | $11,980 | $46,810 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 2,168 | 2,330 | 5,850 | 5,295 |
| Common Shares | 4 | 0 | 0 | 0 | N/A |
| Retained earnings | -19,500 | -12,189 | -2,256 | -1,006 | N/A |
| Other shareholders' equity | -354 | 0 | 0 | 0 | 0 |
| TOTAL | $4,274 | $-6,743 | $-2,256 | $-1,006 | $N/A |
| Total Liabilities And Equity | $4,454 | $3,028 | $9,724 | $45,804 | $0 |